论文信息 - Ensuring global access to COVID-19 vaccines

Ensuring global access to COVID-19 vaccines

Abstract: The current response to the coronavirus disease 2019 (COVID-19) pandemic involves aggressive implementation of suppression strategies, such as case identification, quarantine and isolation, contact tracing, and social distancing However, models developed by the Imperial College COVID-19 Response Team suggest that “transmission will quickly rebound if interventions are relaxed” 1 WHO warns of multiple simultaneous outbreaks of COVID-19 worldwide 2 The development of COVID-19 vaccines that can be used globally is therefore a priority for ending the pandemic

[1] David P. Fidler,et al. Negotiating Equitable Access to Influenza Vaccines: Global Health Diplomacy and the Controversies Surrounding Avian Influenza H5N1 and Pandemic Influenza H1N1 , 2010, PLoS medicine.

[2] C. Whittaker,et al. Report 9: Impact of non-pharmaceutical interventions (NPIs) to reduce COVID19 mortality and healthcare demand , 2020 .

[3] R. Stott,et al. The World Bank , 2008, Annals of tropical medicine and parasitology.

[4] I. Kickbusch,et al. Banking for health: opportunities in cooperation between banking and health applying innovation from other sectors , 2018, BMJ Global Health.

[5] S. Eubank,et al. Commentary on Ferguson, et al., “Impact of Non-pharmaceutical Interventions (NPIs) to Reduce COVID-19 Mortality and Healthcare Demand” , 2020, Bulletin of Mathematical Biology.